Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans.

Ribeiro L, Busnello JV, Cantor RM, Whelan F, Whittaker P, Deloukas P, Wong ML, Licinio J.

Neuroreport. 2007 Aug 6;18(12):1291-3.

2.

Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.

Numata S, Ueno S, Iga J, Yamauchi K, Hongwei S, Ohta K, Kinouchi S, Shibuya-Tayoshi S, Tayoshi S, Aono M, Kameoka N, Sumitani S, Tomotake M, Kaneda Y, Taniguchi T, Ishimoto Y, Ohmori T.

Neurosci Lett. 2006 Jun 19;401(1-2):1-5. Epub 2006 Mar 14.

PMID:
16533563
3.

Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.

Borroni B, Archetti S, Costanzi C, Grassi M, Ferrari M, Radeghieri A, Caimi L, Caltagirone C, Di Luca M, Padovani A; ITINAD Working Group.

Neurobiol Aging. 2009 Sep;30(9):1406-12. doi: 10.1016/j.neurobiolaging.2007.11.023. Epub 2008 Jan 7.

PMID:
18179845
4.

The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression.

Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, Yang YM.

Neurobiol Aging. 2006 Dec;27(12):1834-7. Epub 2005 Dec 15.

PMID:
16343697
5.

Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression.

Anttila S, Huuhka K, Huuhka M, Rontu R, Hurme M, Leinonen E, Lehtimäki T.

J Neural Transm (Vienna). 2007;114(8):1065-8. Epub 2007 Mar 31.

PMID:
17401528
6.

Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients.

Zou YF, Wang Y, Liu P, Feng XL, Wang BY, Zang TH, Yu X, Wei J, Liu ZC, Liu Y, Tao M, Li HC, Li KQ, Hu J, Li M, Zhang KR, Ye DQ, Xu XP.

Neuropsychobiology. 2010;61(2):71-8. doi: 10.1159/000265132. Epub 2009 Dec 12.

PMID:
20016225
7.

Investigation of the functional brain-derived neurotrophic factor gene variant Val66MET in migraine.

Marziniak M, Herzog AL, Mössner R, Sommer C.

J Neural Transm (Vienna). 2008 Sep;115(9):1321-5. doi: 10.1007/s00702-008-0056-1. Epub 2008 May 14. Erratum in: J Neural Transm. 2009 Sep;116(9):1189. Herzog, Andrea [corrected to Herzog, Anna Laura].

PMID:
18478177
8.

Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons.

Takahashi T, Suzuki M, Tsunoda M, Kawamura Y, Takahashi N, Tsuneki H, Kawasaki Y, Zhou SY, Kobayashi S, Sasaoka T, Seto H, Kurachi M, Ozaki N.

Neurosci Lett. 2008 Apr 11;435(1):34-9. doi: 10.1016/j.neulet.2008.02.004. Epub 2008 Feb 9.

PMID:
18325670
9.

Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.

Choi MJ, Kang RH, Lim SW, Oh KS, Lee MS.

Brain Res. 2006 Nov 6;1118(1):176-82. Epub 2006 Sep 18.

PMID:
16979146
10.

Interacting effect of BDNF Val66Met polymorphism and stressful life events on adolescent depression.

Chen J, Li X, McGue M.

Genes Brain Behav. 2012 Nov;11(8):958-65. doi: 10.1111/j.1601-183X.2012.00843.x. Epub 2012 Sep 20.

11.

Association between BDNF Val66Met polymorphism and age at onset in Huntington disease.

Alberch J, López M, Badenas C, Carrasco JL, Milà M, Muñoz E, Canals JM.

Neurology. 2005 Sep 27;65(6):964-5. No abstract available.

PMID:
16186551
12.

Evidence of association between Val66Met polymorphism at BDNF gene and anxiety disorders in a community sample of children and adolescents.

Tocchetto A, Salum GA, Blaya C, Teche S, Isolan L, Bortoluzzi A, Rebelo E Silva R, Becker JA, Bianchin MM, Rohde LA, Leistner-Segal S, Manfro GG.

Neurosci Lett. 2011 Sep 20;502(3):197-200. doi: 10.1016/j.neulet.2011.07.044. Epub 2011 Aug 4.

13.

Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.

Hashim HM, Fawzy N, Fawzi MM, Karam RA.

J Psychiatr Res. 2012 Jun;46(6):762-6. doi: 10.1016/j.jpsychires.2012.03.007. Epub 2012 Apr 21.

PMID:
22521161
14.

Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly.

Miyajima F, Ollier W, Mayes A, Jackson A, Thacker N, Rabbitt P, Pendleton N, Horan M, Payton A.

Genes Brain Behav. 2008 Jun;7(4):411-7. Epub 2007 Oct 31.

15.

Brain-derived neurotrophic factor does not influence age at neurologic onset of Huntington's disease.

Kishikawa S, Li JL, Gillis T, Hakky MM, Warby S, Hayden M, MacDonald ME, Myers RH, Gusella JF.

Neurobiol Dis. 2006 Nov;24(2):280-5. Epub 2006 Sep 7.

PMID:
16962786
16.

Association between brain-derived neurotrophic factor genetic polymorphism Val66Met and susceptibility to bipolar disorder: a meta-analysis.

Wang Z, Li Z, Gao K, Fang Y.

BMC Psychiatry. 2014 Dec 24;14:366. doi: 10.1186/s12888-014-0366-9. Review.

17.

The 196G/A (val66met) polymorphism of the BDNF gene is significantly associated with binge eating behavior in women with bulimia nervosa or binge eating disorder.

Monteleone P, Zanardini R, Tortorella A, Gennarelli M, Castaldo E, Canestrelli B, Maj M.

Neurosci Lett. 2006 Oct 2;406(1-2):133-7. Epub 2006 Aug 9.

PMID:
16901635
18.

The BDNF Val66Met polymorphism predicts rumination and depression differently in young adolescent girls and their mothers.

Hilt LM, Sander LC, Nolen-Hoeksema S, Simen AA.

Neurosci Lett. 2007 Dec 11;429(1):12-6. Epub 2007 Oct 2.

PMID:
17959306
19.

Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder.

Matsuo K, Walss-Bass C, Nery FG, Nicoletti MA, Hatch JP, Frey BN, Monkul ES, Zunta-Soares GB, Bowden CL, Escamilla MA, Soares JC.

Neuropsychopharmacology. 2009 Jul;34(8):1904-13. doi: 10.1038/npp.2009.23. Epub 2009 Mar 18.

20.

Supplemental Content

Support Center